Dopamine (DA) toxicity in pathogenesis and therapy of Parkinson’s disease (PD)
Citations
Altmetric:
Alternative Title
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder that affects 1% of the general population over the age of 60 [1]. PD is characterized by progressive dopamine (DA) neuron degeneration in the pars compacta of the substantia nigra (SN) plus Lewy body formation in affected brain areas [2]. The progressive DA neuron degeneration leads to decreased DA content in SN, contributing to onset of PD symptoms. So far PD is still an incurable human disorder and L-DOPA replenishing therapy is the only treatment, which can transiently alleviate PD symptoms, with no therapeutic effects against DA neurons demise in PD patient brains
Keywords
Source Title
Journal of Clinical and Bioanalytical Chemistry
Publisher
Allied Academies
Series/Report No.
Collections
Rights
Date
2017-10-16
DOI
Type
Article